Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-11

Clinical Trial Update: the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of Cerebrolysin on physical and mental functions in individuals with Down syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cerebrolysin

Snippet

Sponsor: Mansoura University Children Hospital | Conditions: Down Syndrome | Phase 2 | Status: COMPLETED